Hangzhou Flariant Co., Ltd.

Hangzhou Flariant Co., a small-cap specialty chemicals firm, faced a notable stock decline today, marking a 31.16% drop over the past week. The company has reported declining net sales and operating profit over five years, raising concerns about its profitability and financial stability amid a challenging market environment.

Hangzhou Flariant Co., a midcap specialty chemicals firm, saw its stock drop significantly today, despite a strong monthly and yearly performance. The company faces challenges, including low profitability metrics and declining net sales, alongside a high debt-to-equity ratio, reflecting the complexities of its financial situation.

Hangzhou Flariant Co. has demonstrated notable stock performance, with significant gains over various timeframes, including a year-to-date increase of 63.35%. Despite these positive trends, the company faces challenges such as low returns on capital and equity, alongside declining net sales and operating profit in recent years.

Hangzhou Flariant Co., a midcap specialty chemicals firm, has experienced notable stock performance, with significant gains over various timeframes. Despite challenges such as low returns on capital and declining net sales, the company's recent momentum reflects its resilience in a competitive market environment.

Hangzhou Flariant Co., a small-cap specialty chemicals firm, has demonstrated strong stock performance, significantly outperforming the China Shanghai Composite. Despite impressive gains over various time frames, the company faces challenges such as low returns on capital and equity, alongside declining net sales and operating profit in recent years.

Hangzhou Flariant Co., a small-cap specialty chemicals firm, has seen a notable rise in stock performance, significantly outperforming the China Shanghai Composite index over various periods. Despite impressive gains, the company faces challenges such as a low Return on Capital Employed and a high Debt to Equity ratio, raising concerns about profitability.

Hangzhou Flariant Co., a small-cap specialty chemicals firm, saw its stock decline significantly on May 28, 2026, reaching an intraday low. Despite a strong year-on-year gain, the company faces challenges with management efficiency and declining net sales over the past five years, amid a complex financial environment.

Hangzhou Flariant Co. has experienced a notable rise in stock performance, significantly outpacing the broader market. Over the past month, the company has shown impressive growth, with a substantial year-to-date increase. However, it faces challenges, including low returns and declining net sales over the past five years.

Hangzhou Flariant Co., Ltd. has experienced a recent evaluation adjustment, reflecting changes in its valuation metrics. The company faces challenges, including a decline in net sales and low profitability, while technical indicators suggest a more favorable outlook. This highlights the complexities of its current market position.

Hangzhou Flariant Co., a small-cap specialty chemicals firm, saw its stock decline significantly today, reflecting ongoing challenges. The company has experienced notable decreases in stock performance over the past week and month, alongside a concerning annual decline in net sales and operating profit over five years. Its financial health is under scrutiny.